These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
591 related items for PubMed ID: 25275721
41. Long-Term Progression of Pericentral Hydroxychloroquine Retinopathy. Ahn SJ, Seo EJ, Kim KE, Kim YJ, Lee BR, Kim JG, Yoon YH, Lee JY. Ophthalmology; 2021 Jun; 128(6):889-898. PubMed ID: 33129843 [Abstract] [Full Text] [Related]
42. Factors associated with early hydroxychloroquine-induced retinal toxicity in patients with systemic lupus erythematosus. Araújo O, Hernández-Negrín H, Casaroli-Marano RP, Hernández-Rodríguez J, Adán A, Espinosa G, Pelegrín L, Cervera R. Graefes Arch Clin Exp Ophthalmol; 2024 Sep; 262(9):2823-2832. PubMed ID: 38578332 [Abstract] [Full Text] [Related]
46. SEQUENTIAL CHANGES IN HYDROXYCHLOROQUINE RETINOPATHY UP TO 20 YEARS AFTER STOPPING THE DRUG: Implications for Mild Versus Severe Toxicity. Pham BH, Marmor MF. Retina; 2019 Mar; 39(3):492-501. PubMed ID: 30550532 [Abstract] [Full Text] [Related]
47. SEQUENTIAL RETINAL THICKNESS ANALYSIS SHOWS HYDROXYCHLOROQUINE DAMAGE BEFORE OTHER SCREENING TECHNIQUES. Marmor MF, Durbin M, de Sisternes L, Pham BH. Retin Cases Brief Rep; 2021 May 01; 15(3):185-196. PubMed ID: 33394957 [Abstract] [Full Text] [Related]
51. ERG findings in patients using hydroxychloroquine. Tzekov RT, Serrato A, Marmor MF. Doc Ophthalmol; 2004 Jan 01; 108(1):87-97. PubMed ID: 15104171 [Abstract] [Full Text] [Related]
52. Fluorescence Lifetimes in Patients With Hydroxychloroquine Retinopathy. Solberg Y, Dysli C, Möller B, Wolf S, Zinkernagel MS. Invest Ophthalmol Vis Sci; 2019 May 01; 60(6):2165-2172. PubMed ID: 31108547 [Abstract] [Full Text] [Related]
53. Ocular toxicity of hydroxychloroquine. Tehrani R, Ostrowski RA, Hariman R, Jay WM. Semin Ophthalmol; 2008 May 01; 23(3):201-9. PubMed ID: 18432546 [Abstract] [Full Text] [Related]
54. Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography. So SC, Hedges TR, Schuman JS, Quireza ML. Ophthalmic Surg Lasers Imaging; 2003 May 01; 34(3):251-8. PubMed ID: 12757106 [Abstract] [Full Text] [Related]
55. Hydroxychloroquine retinopathy: A review of imaging. Pandya HK, Robinson M, Mandal N, Shah VA. Indian J Ophthalmol; 2015 Jul 01; 63(7):570-4. PubMed ID: 26458473 [Abstract] [Full Text] [Related]
56. Current screening practice in patients under long-term hydroxychloroquine medication in Taiwan: A nationwide population-based cohort study. Yen CY, Lee PH, Yen JC, Chen CC, Hu HY, Tseng PC. Medicine (Baltimore); 2019 Apr 01; 98(14):e15122. PubMed ID: 30946384 [Abstract] [Full Text] [Related]
57. Ocular fundus manifestation of two patients following long-term chloroquine therapy: a case report. Ma X, Yan L, He L, He D, Lu H. Diagn Pathol; 2010 Mar 29; 5():20. PubMed ID: 20346186 [Abstract] [Full Text] [Related]
58. Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test. Tsang AC, Ahmadi Pirshahid S, Virgili G, Gottlieb CC, Hamilton J, Coupland SG. Ophthalmology; 2015 Jun 29; 122(6):1239-1251.e4. PubMed ID: 25824328 [Abstract] [Full Text] [Related]
59. Macular toxicity after short-term hydroxychloroquine therapy. Pasaoglu I, Onmez FE. Indian J Ophthalmol; 2019 Feb 29; 67(2):289-292. PubMed ID: 30672499 [Abstract] [Full Text] [Related]
60. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine. Chang WH, Katz BJ, Warner JE, Vitale AT, Creel D, Digre KB. Retina; 2008 Feb 29; 28(10):1478-86. PubMed ID: 18997610 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]